Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kwa

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1996
Prognostic factors in resected non-small cell lung cancer: an immunohistochemical study of 39 casesH B Kwa, M G Verheijen, S V Litvinov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant scheduleH J Groen, E Fokkema, B Biesma, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 23, 2003
Granular cell tumors of the tracheobronchial treeJ van der Maten, J L G Blaauwgeers, T G Sutedja, et al.
British Journal of Cancer|February 9, 2006
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II studyP Baas, J S A Belderbos, S Senan, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1996
Prognostic factors in resected non-small cell lung cancer: an immunohistochemical study of 39 casesH B Kwa, M G Verheijen, S V Litvinov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant scheduleH J Groen, E Fokkema, B Biesma, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 23, 2003
Granular cell tumors of the tracheobronchial treeJ van der Maten, J L G Blaauwgeers, T G Sutedja, et al.
British Journal of Cancer|February 9, 2006
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II studyP Baas, J S A Belderbos, S Senan, et al.
Pageof 2